Journal article
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data
Abstract
BACKGROUND: To obtain more reliable and precise estimates of the effect of direct thrombin inhibitors in the management of acute coronary syndromes, including patients undergoing percutaneous coronary intervention, we undertook a meta-analysis based on individual patients' data from randomised trials comparing a direct thrombin inhibitor (hirudin, bivalirudin, argatroban, efegatran, or inogatran) with heparin.
METHODS: We included trials that …
Authors
Group TDTITC
Journal
The Lancet, Vol. 359, No. 9303, pp. 294–302
Publisher
Elsevier
Publication Date
January 2002
DOI
10.1016/s0140-6736(02)07495-0
ISSN
0140-6736